Rosalie Viney
Rosalie Viney
Verified email at
Cited by
Cited by
Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study
A Pearce, M Haas, R Viney, SA Pearson, P Haywood, C Brown, R Ward
PloS one 12 (10), e0184360, 2017
Discrete choice experiments to measure consumer preferences for health and healthcare
R Viney, E Lancsar, J Louviere
Expert review of pharmacoeconomics & outcomes research 2 (4), 319-326, 2002
Time trade-off derived EQ-5D weights for Australia
R Viney, R Norman, MT King, P Cronin, DJ Street, S Knox, J Ratcliffe
Value in Health 14 (6), 928-936, 2011
Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer
RC Viney, MJ Boyer, MT King, PM Kenny, CA Pollicino, JM McLean, ...
Journal of Clinical Oncology 22 (12), 2357-2362, 2004
Quality of life and survival in the 2 years after surgery for non–small-cell lung cancer
PM Kenny, MT King, RC Viney, MJ Boyer, CA Pollicino, JM McLean, ...
Journal of Clinical Oncology 26 (2), 233-241, 2008
Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination
J Hall, P Kenny, M King, J Louviere, R Viney, A Yeoh
Health economics 11 (5), 457-465, 2002
Using stated preference discrete choice modeling to evaluate health care programs
J Hall, R Viney, M Haas, J Louviere
Journal of Business research 57 (9), 1026-1032, 2004
International comparisons in valuing EQ-5D health states: a review and analysis
R Norman, P Cronin, R Viney, M King, D Street, J Ratcliffe
Value in Health 12 (8), 1194-1200, 2009
A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states
R Norman, P Cronin, R Viney
Applied health economics and health policy 11, 287-298, 2013
An Australian discrete choice experiment to value EQ‐5D health states
R Viney, R Norman, J Brazier, P Cronin, MT King, J Ratcliffe, D Street
Health Economics 23 (6), 729-742, 2014
Empirical investigation of experimental design properties of discrete choice experiments in health care
R Viney, E Savage, J Louviere
Health Economics 14 (4), 349-362, 2005
Valuing SF-6D health states using a discrete choice experiment
R Norman, R Viney, J Brazier, L Burgess, P Cronin, M King, J Ratcliffe, ...
Medical Decision Making 34 (6), 773-786, 2014
Preferences for cancer treatments: an overview of methods and applications in oncology
P Blinman, M King, R Norman, R Viney, MR Stockler
Annals of oncology 23 (5), 1104-1110, 2012
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
MT King, DSJ Costa, NK Aaronson, JE Brazier, DF Cella, PM Fayers, ...
Quality of Life Research 25, 625-636, 2016
Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review
B Parkinson, C Sermet, F Clement, S Crausaz, B Godman, S Garner, ...
Pharmacoeconomics 33, 905-924, 2015
Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task
R Norman, MT King, D Clarke, R Viney, P Cronin, D Street
Quality of Life Research 19, 499-508, 2010
Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30
MT King, R Viney, A Simon Pickard, D Rowen, NK Aaronson, JE Brazier, ...
Pharmacoeconomics 36, 225-238, 2018
Carrots and sticks—the fall and fall of private health insurance in Australia
J Hall, R de Abreu Lourenco, R Viney
Health Economics 8 (8), 653-660, 1999
Breaking up is hard to do: why disinvestment in medical technology is harder than investment
M Haas, J Hall, R Viney, G Gallego
Australian Health Review 36 (2), 148-152, 2012
The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002–4
PA Scuffham, JA Whitty, A Mitchell, R Viney
Pharmacoeconomics 26, 297-310, 2008
The system can't perform the operation now. Try again later.
Articles 1–20